Roflumilast is used for treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD) exacerbations in ...

Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

The shares of Senores Pharmaceuticals Limited were trading at ₹570.70 up by ₹36.90 or 6.91% on the NSE today at 2.32 pm.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Once-daily roflumilast cream at 0.15% improved symptoms of atopic dermatitis (AD) across multiple end points.

Expert Rev Resp Med. 2008;2(5):539-549. Results from human subjects have also demonstrated significant pulmonary anti-inflammatory effects of roflumilast. In a randomized, placebo-controlled ...

Roflumilast (ALTANA Pharma AG), a phosphodiesterase-4 (PDE4) inhibitor, is being developed for the management of chronic obstructive pulmonary disease (COPD) and asthma. Its once-daily oral ...

Senores Pharmaceutical added 2.18% to Rs 546.15 after the company's wholly owned subsidiary, Senores Pharmaceuticals, Inc., USA has signed an agreement to acquire Roflumilast 250 mcg and 500 mcg ...

A 0.15% once-daily roflumilast cream improved symptoms of atopic dermatitis (AD) across multiple endpoints, according to ...

My thesis was essentially that the company, which markets and sells Zoryve (roflumilast) topical cream, and Zoryve foam, to treat patients with plaque psoriasis, and mild-to-moderate atopic ...